EUVIMED · CrossrefJournal
Med
ISSN 2666-6340 · Elsevier BV
Latest articles
One class, different indications: Factor XIa inhibition after LIBREXIA-ACS
Once-weekly oral islatravir/lenacapavir: Closer to clinical practice?
Clinical readiness of foundation and agentic AI in computational pathology
Red-cell DNA opens new avenues for early detection of gastric cancer
The promise and limitations of cell-free DNA fragmentomics for hepatocellular carcinoma surveillance
Idiopathic pulmonary fibrosis: Five trials to watch
Geographic disparities and aging-related burden in reperfusion service output for acute ischemic stroke in China: A national sample spatial analysis
First-line treatment of gastric cancer: Five trials to watch
Imaging-detected extranodal extension grading and T-category adjustment to refine the TNM-9 classification for nasopharyngeal carcinoma
Neuropathic pain: Opportunities and challenges for immune-based therapeutics
Targeting MAP1A overcomes immunotherapy resistance in triple-negative breast cancer by restoring tumor antigen presentation via JAK1-STAT1 inhibition
Maintenance ketamine infusions for treatment-resistant bipolar depression: An open-label extension trial
Atrial fibrillation is associated with higher stroke risk but not with higher mortality in patients with heart failure: A nationwide analysis
Continual learning in oncology AI: A framework for safe clinical translation
N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy
Interpretation of genome sequencing results in children with complex neuromotor phenotypes
Metabolic endotyping for mechanism-informed Alzheimer’s and Parkinson’s disease trials
Tissue-reactive zonation of mesenchymal-like phenotypes in human glioblastoma
Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapy
A third way to breathe
Inhibiting glycan degradation prevents HIV-induced inflammaging and cognitive impairment
The atlas of abdominal organ remodeling in hepatocellular carcinoma patients: An artificial intelligence-based multicenter imaging study
Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO)
Antibody-drug conjugates and the need for third-modality regulatory science
Atlas of human brain imaging-derived phenotypes and disease risk
Another complement inhibitor therapy for myasthenia gravis: Is it NIMBLE enough?
Systemic lupus erythematosus: Phase 2 trials to watch in 2026
Adipose macrophage heterogeneity: A potential immunometabolic target for preventing weight regain
Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation
Inhaled treprostinil and the vascular turn in pulmonary fibrosis
EUVIMED